Fidelity Investments’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-100
| Closed | -$1K | – | 4469 |
|
|
2020
Q3 | $1K | Buy |
+100
| New | +$951 | ﹤0.01% | 3630 |
|
|
2020
Q1 | – | Sell |
-1,000
| Closed | -$12K | – | 4488 |
|
|
2019
Q4 | $12K | Sell |
1,000
-300
| -23% | -$3.28K | ﹤0.01% | 3240 |
|
|
2019
Q3 | $15K | Buy |
1,300
+1,000
| +333% | +$10.5K | ﹤0.01% | 3147 |
|
|
2019
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 3497 |
|
|
2019
Q1 | $4K | Sell |
300
-3,600
| -92% | -$53.6K | ﹤0.01% | 3331 |
|
|
2018
Q4 | $59K | Sell |
3,900
-1,858,368
| -100% | -$35.4M | ﹤0.01% | 2699 |
|
|
2018
Q3 | $37.2M | Sell |
1,862,268
-129,100
| -6% | -$2.94M | ﹤0.01% | 1413 |
|
|
2018
Q2 | $38.8M | Buy |
1,991,368
+658,100
| +49% | +$14.6M | ﹤0.01% | 1409 |
|
|
2018
Q1 | $26.9M | Sell |
1,333,268
-309,886
| -19% | -$5.24M | ﹤0.01% | 1589 |
|
|
2017
Q4 | $21.8M | Sell |
1,643,154
-209,800
| -11% | -$3.16M | ﹤0.01% | 1682 |
|
|
2017
Q3 | $34.2M | Sell |
1,852,954
-111,200
| -6% | -$2.07M | ﹤0.01% | 1488 |
|
|
2017
Q2 | $36.1M | Sell |
1,964,154
-136,100
| -6% | -$2.7M | ﹤0.01% | 1436 |
|
|
2017
Q1 | $47.4M | Sell |
2,100,254
-980,255
| -32% | -$23.5M | 0.01% | 1327 |
|
|
2016
Q4 | $107M | Sell |
3,080,509
-340,845
| -10% | -$10.2M | 0.01% | 958 |
|
|
2016
Q3 | $83.9M | Sell |
3,421,354
-728,909
| -18% | -$18.2M | 0.01% | 1066 |
|
|
2016
Q2 | $99.3M | Sell |
4,150,263
-55,440
| -1% | -$1.27M | 0.01% | 976 |
|
|
2016
Q1 | $98.4M | Sell |
4,205,703
-999,885
| -19% | -$23.7M | 0.01% | 968 |
|
|
2015
Q4 | $157M | Buy |
5,205,588
+103,035
| +2% | +$3.33M | 0.02% | 757 |
|
|
2015
Q3 | $203M | Buy |
5,102,553
+522,808
| +11% | +$32.5M | 0.03% | 623 |
|
|
2015
Q2 | $316M | Buy |
4,579,745
+53,734
| +1% | +$3.38M | 0.04% | 478 |
|
|
2015
Q1 | $247M | Buy |
4,526,011
+3,227,267
| +248% | +$154M | 0.03% | 594 |
|
|
2014
Q4 | $55.4M | Sell |
1,298,744
-126,000
| -9% | -$4.55M | 0.01% | 1280 |
|
|
2014
Q3 | $45.5M | Buy |
1,424,744
+280,871
| +25% | +$5.99M | 0.01% | 1342 |
|
|
2014
Q2 | $23.7M | Sell |
1,143,873
-3,784
| -0.3% | -$69.9K | ﹤0.01% | 1719 |
|
|
2014
Q1 | $22.2M | Sell |
1,147,657
-122,527
| -10% | -$2.6M | ﹤0.01% | 1702 |
|
|
2013
Q4 | $30.8M | Sell |
1,270,184
-605,876
| -32% | -$14.2M | ﹤0.01% | 1542 |
|
|
2013
Q3 | $40.3M | Sell |
1,876,060
-181,828
| -9% | -$4.3M | 0.01% | 1385 |
|
|
2013
Q2 | $45.8M | Buy |
+2,057,888
| New | +$45.3M | 0.01% | 1282 |
|
Fidelity Investments's AMAG Position: Q4 2020 in Review
Fidelity Investments sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 100 shares — an estimated $1K sold.
Fidelity Investments first reported a position in AMAG in Q2 2013 and held it in 28 quarters. The position peaked at $316M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Fidelity Investments reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Fidelity Investments sold 100 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1K.
- Fidelity Investments first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 28 quarters.
- Fidelity Investments's AMAG Pharmaceuticals position peaked at $316M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Fidelity Investments's 13F filing for Q4 2020, filed 8 Feb 2021.